RTA Laboratuvarlari Biyolojik (RTALB) - Total Liabilities

Latest as of June 2025: TL103.51 Million TRY ≈ $2.32 Million USD

Based on the latest financial reports, RTA Laboratuvarlari Biyolojik (RTALB) has total liabilities worth TL103.51 Million TRY (≈ $2.32 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

RTA Laboratuvarlari Biyolojik - Total Liabilities Trend (2010–2024)

This chart illustrates how RTA Laboratuvarlari Biyolojik's total liabilities have evolved over time, based on quarterly financial data. See RTALB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

RTA Laboratuvarlari Biyolojik Competitors by Total Liabilities

The table below lists competitors of RTA Laboratuvarlari Biyolojik ranked by their total liabilities.

Company	Country	Total Liabilities
3S KOREA Co. Ltd KQ:060310	Korea	₩14.25 Billion
EYG Gayrimenkul Yatirim Ortakligi A.S. IS:EYGYO	Turkey	TL758.51 Million
Pakka Limited NSE:PAKKA	India	Rs6.46 Billion
Euro Yatirim Holding AS IS:EUHOL	Turkey	TL29.12 Million
Kyung Chang Industrial Co. Ltd KQ:024910	Korea	₩360.97 Billion
Müller - Die lila Logistik AG XETRA:MLL	Germany	€152.19 Million
Donaco International Ltd AU:DNA	Australia	AU$45.17 Million
Hung Chou Fiber Ind Co Ltd TW:1413	Taiwan	NT$1.50 Billion

Liability Composition Analysis (2010–2024)

This chart breaks down RTA Laboratuvarlari Biyolojik's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of RTA Laboratuvarlari Biyolojik.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.24	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how RTA Laboratuvarlari Biyolojik's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for RTA Laboratuvarlari Biyolojik (2010–2024)

The table below shows the annual total liabilities of RTA Laboratuvarlari Biyolojik from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	TL252.17 Million ≈ $5.65 Million	+34.30%
2023-12-31	TL187.77 Million ≈ $4.21 Million	+74.71%
2022-12-31	TL107.47 Million ≈ $2.41 Million	-48.62%
2021-12-31	TL209.17 Million ≈ $4.68 Million	+135.77%
2020-12-31	TL88.72 Million ≈ $1.99 Million	+673.78%
2019-12-31	TL11.47 Million ≈ $256.80K	+27.53%
2018-12-31	TL8.99 Million ≈ $201.36K	+1.68%
2017-12-31	TL8.84 Million ≈ $198.03K	-17.29%
2016-12-31	TL10.69 Million ≈ $239.43K	-28.15%
2015-12-31	TL14.88 Million ≈ $333.23K	+30.52%
2014-12-31	TL11.40 Million ≈ $255.31K	+33.81%
2013-12-31	TL8.52 Million ≈ $190.80K	-9.94%
2012-12-31	TL9.46 Million ≈ $211.86K	+47.52%
2011-12-31	TL6.41 Million ≈ $143.61K	+18.89%
2010-12-31	TL5.39 Million ≈ $120.79K	--

About RTA Laboratuvarlari Biyolojik

IS:RTALB Turkey Biotechnology

Market Cap

$39.31 Million

TL1.75 Billion TRY

Market Cap Rank

#22804 Global

#398 in Turkey

Share Price

TL3.51

Change (1 day)

+0.29%

52-Week Range

TL2.60 - TL4.71

All Time High

TL29.60